Notably, CHIP could negatively regulate microtubule-associated serine/threonine kinase 1 (MAST1) to induce MAST1 ubiquitination and degradation, and Hsp90β could interact with and stabilize MAST1 in cisplatin-resistant cancer cells [14]. The gene discussed is MAST1; the disease is cancer.